NASDAQ:ASMB

Assembly Biosciences (ASMB) Stock Forecast, Price & News

$1.08

-0.03 (-2.70%)

(As of 06/9/2023 ET)

Compare

Today's Range: $1.05
▼
$1.12
50-Day Range: $0.81
▼
$1.13
52-Week Range: $0.77
▼
$2.42

Volume: 121,355 shs
Average Volume: 230,871 shs
Market Capitalization: $56.29 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.17

Assembly Biosciences MarketRank™ Forecast

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 100.6% Upside
$2.17 Price Target
Short Interest: Healthy
0.31% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.71
Upright™ Environmental Score
News Sentiment: 0.09
Based on 35 Articles This Week
Insider Trading: Selling Shares
$55,227 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.33) to ($0.80) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

109th out of 987 stocks

Pharmaceutical Preparations Industry

47th out of 478 stocks

3.2

Analyst's Opinion

Consensus Rating
Assembly Biosciences has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.17, Assembly Biosciences has a forecasted upside of 100.6% from its current price of $1.08.
Amount of Analyst Coverage
Assembly Biosciences has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.31% of the outstanding shares of Assembly Biosciences have been sold short.
Short Interest Ratio / Days to Cover
Assembly Biosciences has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Assembly Biosciences has recently decreased by 5.45%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Assembly Biosciences does not currently pay a dividend.
Dividend Growth
Assembly Biosciences does not have a long track record of dividend growth.

4.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Assembly Biosciences has received a 74.27% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Preclinical research services for physical health", "Clinical research services for infectious diseases", and "Basic medical research services" products. See details.
Environmental Sustainability
The Environmental Impact score for Assembly Biosciences is -0.71.

2.8

News and Social Media Coverage

News Sentiment
Assembly Biosciences has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 35 news articles for Assembly Biosciences this week, compared to 23 articles on an average week.
Search Interest
3 people have searched for ASMB on MarketBeat in the last 30 days.
MarketBeat Follows
1 people have added Assembly Biosciences to their MarketBeat watchlist in the last 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Assembly Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,227.00 in company stock.
Percentage Held by Insiders
Only 4.40% of the stock of Assembly Biosciences is held by insiders.
Percentage Held by Institutions
Only 34.02% of the stock of Assembly Biosciences is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Assembly Biosciences are expected to grow in the coming year, from ($1.33) to ($0.80) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Assembly Biosciences is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Assembly Biosciences is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Assembly Biosciences has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Assembly Biosciences (NASDAQ:ASMB) Stock

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Receive ASMB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat's FREE daily newsletter.

ASMB Stock News Headlines

June 9, 2023 | msn.com

London Assembly opposes English National Opera move

June 9, 2023 | msn.com

Wasn’t me! Assembly Speaker Carl Heastie’s car triggers speed camera 11 times – blames staffers

June 9, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

June 9, 2023 | cbsnews.com

KCAL News Investigates: Chair of State Assembly Transportation Committee questions why Caltrans has cut back efforts to make vital freeway repairs

June 9, 2023 | msn.com

Assembly Atlanta film studio slated to begin operations by end of the summer

June 8, 2023 | msn.com

Assembly underway on temporary bridge for Highway 133

June 8, 2023 | msn.com

Ho Municipal Assembly workers strike over revocation of Finance Officer’s privileges

June 8, 2023 | chron.com

On the final night of the General Assembly, a revised housing bill passes just before adjournment

June 9, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

June 8, 2023 | msn.com

North Carolina General Assembly OKs online sports betting; bill awaits Gov. Cooper’s signature

June 8, 2023 | msn.com

Ronnie V Lyngdoh recognized as leader of opposition in Meghalaya Legislative Assembly

June 8, 2023 | msn.com

Coroner identifies victim in Assembly Street shooting

June 8, 2023 | forbes.com

California Assembly Passes Bill Prohibiting Autonomous Trucks On State’s Roads Without Drivers

June 7, 2023 | msn.com

South Carolina General Assembly’s special session rolls on with no end in sight

June 7, 2023 | msn.com

Penalties in overdose deaths and the professional licenses backlog. Here are key issues before the state Assembly today

June 7, 2023 | foxnews.com

Wisconsin Assembly to approve bills aimed at improving license processing for nurses, doctors

June 7, 2023 | msn.com

National Assembly speaker rules out vote to overturn French pension law

June 7, 2023 | finance.yahoo.com

Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL International Liver Congress™ 2023

June 6, 2023 | nj.com

N.J. election results: State Senate, Assembly primary elections 2023

June 6, 2023 | msn.com

One dead in shooting on Assembly Street in downtown Columbia

June 6, 2023 | msn.com

World Health Assembly nod signals revolution in Africa’s diagnostics

June 6, 2023 | msn.com

Man shot and killed on downtown Columbia’s Assembly Street, shutting down area traffic

June 6, 2023 | msn.com

Insurance bill passes Assembly; Aid in Dying bill vetoed

June 6, 2023 | msn.com

Republicans walk off Assembly floor during Pride Month celebration

June 5, 2023 | news.yahoo.com

Your Daily Briefing: The best bites at Assembly Food Hall, ranked

June 5, 2023 | msn.com

LIVE: Gov. Whitmer travels to GM Flint Assembly for major announcement

June 4, 2023 | msn.com

Pine Lake Assembly Beach remains under advisory

See More Headlines

ASMB Price History

30 days | 90 days | 365 days | Advanced Chart

ASMB Company Calendar

Last Earnings: 3/22/2023
Today: 6/09/2023
Next Earnings (Estimated): 8/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Sector: Medical
Current Symbol: NASDAQ:ASMB
CUSIP: 92282210
CIK: 1426800
Web: www.assemblybio.com
Phone: (833) 509-4583
Fax: 646-706-5101
Employees: 102
Year Founded: 2005

Price Target and Rating

Average Stock Price Forecast: $2.17
High Stock Price Forecast: $3.00
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +95.2%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.82)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-93,090,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -93.79%
Return on Assets: -79.09%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.00
Quick Ratio: 8.00

Sales & Book Value

Annual Sales: $6.25 million
Price / Sales: 9.26
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.69 per share
Price / Book: 0.66

Miscellaneous

Outstanding Shares: 52,120,000
Free Float: 49,828,000
Market Cap: $57.85 million
Optionable: Optionable
Beta: 0.68

Social Links

Key Executives

Jason A. Okazaki
President, Chief Executive Officer & Director

William Delaney
Chief Scientific Officer

John O. Gunderson
Secretary, Vice President & General Counsel

Michele Anderson
Chief Development Officer

Nicole S. White
Chief Manufacturing Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ASMB Stock - Frequently Asked Questions

Should I buy or sell Assembly Biosciences stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Assembly Biosciences in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ASMB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ASMB, but not buy additional shares or sell existing shares.
View ASMB analyst ratings or view top-rated stocks.
What is Assembly Biosciences' stock price forecast for 2023?: 3 brokers have issued 1 year price targets for Assembly Biosciences' stock. Their ASMB share price forecasts range from $1.50 to $3.00. On average, they expect the company's stock price to reach $2.17 in the next year. This suggests a possible upside of 95.2% from the stock's current price.
View analysts price targets for ASMB or view top-rated stocks among Wall Street analysts.
How have ASMB shares performed in 2023?: Assembly Biosciences' stock was trading at $1.30 at the start of the year. Since then, ASMB shares have decreased by 14.6% and is now trading at $1.11.
View the best growth stocks for 2023 here.
Are investors shorting Assembly Biosciences?: Assembly Biosciences saw a drop in short interest in May. As of May 15th, there was short interest totaling 161,300 shares, a drop of 5.5% from the April 30th total of 170,600 shares. Based on an average daily volume of 214,900 shares, the short-interest ratio is presently 0.8 days.
View Assembly Biosciences' Short Interest.
When is Assembly Biosciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our ASMB earnings forecast.
How were Assembly Biosciences' earnings last quarter?: Assembly Biosciences, Inc. (NASDAQ:ASMB) posted its quarterly earnings data on Wednesday, March, 22nd. The biopharmaceutical company reported ($0.46) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.10.
What ETF holds Assembly Biosciences' stock ?: ETFMG Treatments Testing and Advancements ETF holds 16,315 shares of ASMB stock, representing 0.07% of its portfolio.
What is John McHutchison's approval rating as Assembly Biosciences' CEO?: 8 employees have rated Assembly Biosciences Chief Executive Officer John McHutchison on Glassdoor.com. John McHutchison has an approval rating of 80% among the company's employees. 76.0% of employees surveyed would recommend working at Assembly Biosciences to a friend.

What other stocks do shareholders of Assembly Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Assembly Biosciences investors own include BioDelivery Sciences International (BDSI), Exelixis (EXEL), TG Therapeutics (TGTX), Arbutus Biopharma (ABUS), AVEO Pharmaceuticals (AVEO), Sorrento Therapeutics (SRNE), AbbVie (ABBV), BioCryst Pharmaceuticals (BCRX), Gilead Sciences (GILD) and Blueprint Medicines (BPMC).
What is Assembly Biosciences' stock symbol?: Assembly Biosciences trades on the NASDAQ under the ticker symbol "ASMB."
Who are Assembly Biosciences' major shareholders?: Assembly Biosciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.08%), Hudson Bay Capital Management LP (1.82%), Platinum Investment Management Ltd. (1.71%), Renaissance Technologies LLC (1.47%), Federated Hermes Inc. (0.70%) and Dimensional Fund Advisors LP (0.55%). Insiders that own company stock include Jacqueline Sybil Papkoff, Jason A Okazaki, Jeanette M Bjorkquist, John G Mchutchison, Luisa M Stamm, Michael P Samar, Timothy A Springer, William E Iv Delaney and William E Iv Delaney.
View institutional ownership trends.
How do I buy shares of Assembly Biosciences?: Shares of ASMB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Assembly Biosciences' stock price today?: One share of ASMB stock can currently be purchased for approximately $1.11.
How much money does Assembly Biosciences make?: Assembly Biosciences (NASDAQ:ASMB) has a market capitalization of $57.85 million and generates $6.25 million in revenue each year. The biopharmaceutical company earns $-93,090,000.00 in net income (profit) each year or ($1.82) on an earnings per share basis.
How many employees does Assembly Biosciences have?: The company employs 102 workers across the globe.
How can I contact Assembly Biosciences?: Assembly Biosciences' mailing address is 331 OYSTER POINT BOULEVARD FOURTH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.assemblybio.com. The biopharmaceutical company can be reached via phone at (833) 509-4583, via email at lglaser@assemblybio.com, or via fax at 646-706-5101.

This page (NASDAQ:ASMB) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Assembly Biosciences (ASMB) Stock Forecast, Price & News

Assembly Biosciences MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Assembly Biosciences (NASDAQ:ASMB) Stock

ASMB Stock News Headlines

ASMB Price History

ASMB Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

ASMB Stock - Frequently Asked Questions

Overall MarketRank^™